HighTide Therapeutics Announces HTD1801 Meets the Primary Endpoints in Two Phase 3 Clinical Trials in Patients with Type 2 Diabetes Mellitus HONG KONG - April 15, 2025 (NEWMEDIAWIRE) - HighTide ...

Researchers have discovered in a new study that women diagnosed with gestational diabetes mellitus (GDM) earlier than 24 ...

The research team noted that racial subgroups are underrepresented in clinical trials, a factor that should be addressed in ...

Corcept Therapeutics Incorporated’s CORT share price has surged by 7.18%, which has investors questioning if this is right time to sell.

The following is a summary of "Impact of Peripheral Arterial Disease on Clinical Outcomes of Patients Undergoing Complex vs ...

The results were further supported by confirmatory secondary endpoints showing ... semaglutide for people with PAD and Type 2 diabetes mellitus as a therapy that has cardiometabolic ...

A heart expert has said that three foods available in all supermarkets can prevent life-threatening heart attacks and ...

The results were further supported by confirmatory secondary endpoints showing significant improvements ... "Taken together, the data support semaglutide for people with PAD and type 2 diabetes ...

The FDA has granted approval to nivolumab plus ipilimumab for use in unresectable or metastatic hepatocellular carcinoma.

Living in a tropical country like India, our bodies and lifestyle must be adaptable to endure the scorching sun. Sweat-related skin conditions, infections and r ...